Monica Gandhi to Female
This is a "connection" page, showing publications Monica Gandhi has written about Female.
Connection Strength
0.120
-
COVID-19 Susceptibility and Outcomes Among People Living With HIV in San Francisco. J Acquir Immune Defic Syndr. 2021 01 01; 86(1):19-21.
Score: 0.012
-
Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020 12 01; 34(15):2328-2331.
Score: 0.012
-
Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):e158-e160.
Score: 0.011
-
Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART. J Infect Dis. 2018 06 20; 218(2):234-238.
Score: 0.010
-
Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e101-e103.
Score: 0.010
-
Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):367-371.
Score: 0.010
-
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS. 2017 Oct 23; 31(16):2245-2251.
Score: 0.010
-
Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44:499-523.
Score: 0.004
-
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518.
Score: 0.003
-
SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021 06; 8(6):e334-e341.
Score: 0.003
-
Evaluation of a novel community-based COVID-19 'Test-to-Care' model for low-income populations. PLoS One. 2020; 15(10):e0239400.
Score: 0.003
-
Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):347-351.
Score: 0.003
-
Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial. J Int AIDS Soc. 2018 07; 21 Suppl 4:e25115.
Score: 0.003
-
Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania. AIDS. 2018 06 01; 32(9):1115-1123.
Score: 0.003
-
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):169-174.
Score: 0.003
-
Loneliness in Older Adults Living with HIV. AIDS Behav. 2018 05; 22(5):1475-1484.
Score: 0.003
-
Discriminating ability of Cirrus and RTVue optical coherence tomography in different stages of glaucoma. Indian J Ophthalmol. 2018 05; 66(5):675-680.
Score: 0.003
-
Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value. AIDS Behav. 2018 04; 22(4):1165-1173.
Score: 0.003
-
A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients. Pharmacotherapy. 2017 12; 37(12):1498-1506.
Score: 0.002
-
Individual and partnership factors associated with anticipated versus actual partner notification following STI diagnosis among men who have sex with men and/or with transgender women in Lima, Peru. Sex Transm Infect. 2018 12; 94(8):607-610.
Score: 0.002
-
Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):55-59.
Score: 0.002
-
Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women's Interagency HIV Study. BMJ Open. 2017 06 30; 7(6):e013993.
Score: 0.002
-
Treatment switching in South Indian patients on HAART: what are the predictors and consequences? AIDS Care. 2011 May; 23(5):569-77.
Score: 0.002
-
Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection. J Acquir Immune Defic Syndr. 2008 Jul 01; 48(3):360-1.
Score: 0.001
-
Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Clin Infect Dis. 2008 Jan 15; 46(2):305-12.
Score: 0.001